The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care
The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. FDA
The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care
A virtual science conference on One Health: Integrating Human, Animal and Environmental Health will be held 3 December 2021. The One Health movement, which has come to prominence in the last decade, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to
The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” The next webinar in the series on December 8 will
The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16, 2021, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness, response, and recovery. A more detailed agenda will be available
The National Academies of Sciences, Engineering, and Medicine will convene a virtual workshop on January 14, 2022 to examine changes to diagnostic paradigms in response to the COVID-19 pandemic and to consider the lessons learned and opportunities for improving diagnosis within the U.S. health care system. The workshop will be accessible to the public via
The National Academies will host a meeting 9-10 February 2022 to discuss the current understanding of animal welfare challenges in research on wildlife and biologically diverse vertebrate animal species. Research to advance understanding of the ecology and biology of wildlife species is more important than ever as the world confronts issues ranging from biodiversity loss
The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. Join federal leaders, National Biodefense Science Board members, distinguished guests, and other experts to discuss topics related to the public health supply chain and climate change. NBSB will hear from
